Thymosin Alpha-1

Research Benefits

• Immune Modulation — Thymosin Alpha-1 (Tα1) is a 28-amino acid peptide naturally produced by the thymus that has been extensively studied for its immunomodulatory properties, including enhancement of T-cell function and dendritic cell maturation.
• Toll-Like Receptor Activation — Tα1 activates TLR2, TLR5, and TLR9, bridging innate and adaptive immunity and making it a research tool for studying immune priming mechanisms.
• Viral Hepatitis Research — Published studies have explored Tα1 in the context of hepatitis B and C, where it has been shown to enhance antiviral immune responses in preclinical models.
• Vaccine Adjuvant Studies — Tα1 has been investigated as an immune adjuvant, with studies suggesting it enhances antibody and cell-mediated responses to co-administered antigens.
• Cancer Immunology — Research has examined Tα1's ability to enhance anti-tumor immune surveillance through NK cell activation and cytotoxic T-lymphocyte priming.

Mechanism of Action

Thymosin Alpha-1 is an N-terminally acetylated 28-amino acid peptide produced by thymic epithelial cells. It plays a central role in T-cell maturation and immune regulation.

TLR Signaling: Tα1 activates Toll-like receptors (TLR2, TLR5, TLR9) on dendritic cells and macrophages. This triggers MyD88-dependent signaling cascades leading to NF-κB activation and pro-inflammatory cytokine production (IL-12, IFN-α), which prime adaptive immune responses.

T-Cell Differentiation: Tα1 promotes the differentiation of CD4+ and CD8+ T-cell precursors in the thymus by upregulating T-cell receptor (TCR) expression and co-stimulatory molecules (CD80, CD86). It also enhances the Th1/Th2 balance toward Th1 responses.

Dendritic Cell Maturation: By promoting dendritic cell maturation and antigen-presenting capacity, Tα1 enhances the bridge between innate pathogen recognition and adaptive immune activation.

NK Cell Enhancement: Tα1 augments natural killer cell cytotoxicity through upregulation of activating receptors (NKG2D, NKp46), contributing to innate antiviral and anti-tumor surveillance.

Research Protocol

The following information is derived from published research literature and is intended for reference in research settings only.

Reconstitution

Reconstitute lyophilized Tα1 with sterile bacteriostatic water or physiological saline. Typical reconstitution yields 1.6 mg/mL solutions.

Research Dosing (from published studies)

• In vivo (murine): 0.1-1.0 mg/kg subcutaneous, typically administered daily or every other day.
• In vitro: 0.1-100 ng/mL in culture media for immune cell stimulation assays.
• Adjuvant studies: Co-administered with antigen at time of immunization and boosted on days 7 and 14.

Experimental Duration

Immune profiling studies typically run 2-4 weeks. Viral challenge models may extend to 8-12 weeks. Cytokine readouts are assessed at 6, 24, 48, and 72 hours post-dose for kinetics studies.

Storage

Store lyophilized at -20°C. Reconstituted at 2-8°C, use within 28 days.

Safety & Handling

Research Use Only. This product is not intended for human or veterinary diagnostic or therapeutic use.

Storage Conditions

• Lyophilized: -20°C, protected from light and moisture
• Reconstituted: 2-8°C, use within 28 days
• Stable through multiple reconstitution cycles when handled properly

Known Considerations from Literature

• Tα1 has an extensive safety profile in published research with minimal adverse effects reported at standard doses.
• As an immunostimulant, it should be used cautiously in autoimmune disease models where immune activation could exacerbate pathology.
• Potential synergy with other immunomodulators (interferons, checkpoint inhibitors) should be titrated carefully.
• Injection site reactions have been noted in some animal studies at higher concentrations.

Handling

Use standard laboratory PPE. Maintain sterile technique during reconstitution and aliquoting. Dispose per institutional guidelines.

Frequently Asked Questions

What is Thymosin Alpha-1?

Thymosin Alpha-1 is a naturally occurring 28-amino acid peptide produced by thymic epithelial cells. It was first isolated from thymosin fraction 5 and plays a key role in immune system development and regulation.

What immune cells does Tα1 affect?

Tα1 primarily enhances T-cell differentiation (both CD4+ and CD8+), dendritic cell maturation, and NK cell cytotoxicity. It also activates macrophages through Toll-like receptor signaling.

How is Tα1 different from other thymic peptides?

Tα1 is a defined, single-sequence peptide with well-characterized receptor targets (TLR2/5/9), unlike crude thymic extracts which contain heterogeneous mixtures. This makes it suitable for controlled, reproducible research.

What purity is this product?

BeaCapra Thymosin Alpha-1 is ≥99% pure by HPLC with full COA documentation available for each batch.

Is Tα1 stable in solution?

Reconstituted Tα1 is relatively stable compared to many peptides, maintaining activity for up to 28 days at 2-8°C. For long-term storage, lyophilized form at -20°C is recommended.